Nonsense :) For him is important prestige. He can not afford to lose prestige. No one wouldn't believed him in contracting.
No offense, but VITAROS is absolutely a different drug. BTW: I was in APRI (I sold all at $5.3) IMHO VITAROS has not any future. Also approved only in CANADA if nothing has changed since then.
Sentiment: hold / add more
This ophthalmology forum doesn't so important for RXII now
Investopedia explains 'NYSE Arca'
As of 2009, The NYSE Arca is the world's second largest electronic communication network (ECN) in terms of shares traded. It accounts for roughly 10% of NYSE-listed securities traded and 20% of Nasdaq-listed securities traded. Much like other ECNs, the NYSE Arca implements a liquidity fee/rebate program to improve overall market liquidity.